Products

Have an Emergency?

For urgent assistance, please contact emergency response services.

Call: 911

Product Questions?

Questions, comments or concerns about Rising Pharmaceuticals products? Contact one of our trusted professionals today.

Call (800) 521-5340
info@risingpharma.com

Compare Products

Compares to the labeled active ingredients in Reference Brand. The trademark or tradename referenced is NOT registered, owned or licensed by Rising Pharmaceuticals, Inc. or its affiliates.

A chemotherapy drug used to treat brain cancer.

Temozolomide Capsules Temozolomide Capsules Temozolomide Capsules Temozolomide Capsules Temozolomide Capsules Temozolomide Capsules Temozolomide Capsules Temozolomide Capsules Temozolomide Capsules Temozolomide Capsules Temozolomide Capsules

Temozolomide Capsules

Compare to: Temodar® Capsules*
Strength: 5mg | 20mg | 100mg | 140mg | 180mg | 250mg
* Temodar® Capsules is a registered trademark of Merck & Co, Inc.
This information has been designed as a quick reference. It is intended as a reference source only and not for prescribing or dispensing product. The appropriate approved prescribing information should be consulted. Images viewed herein may appear different than they do when viewing them live because of computer and/or photographic distortion. In addition, over time, some images and information for a particular product may change. For the most up-to-date product information, please contact your pharmacist or physician.

1.1 Newly Diagnosed Glioblastoma Multiforme

Temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment.

 

1.2  Refractory Anaplastic Astrocytoma

Temozolomide capsules are indicated for the treatment of adult patients with refractory anaplastic astrocytoma, i.e., patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.